These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9220308)

  • 21. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors.
    Guazzi M; Pontone G; Agostoni P
    Am Heart J; 1999 Aug; 138(2 Pt 1):254-60. PubMed ID: 10426836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Do vasodilators help in chronic heart failure?].
    Slany J
    Wien Klin Wochenschr; 1987 Mar; 99(5):139-44. PubMed ID: 2883777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose.
    Reid JL; MacFadyen RJ; Squire IB; Lees KR
    Am Heart J; 1993 Sep; 126(3 Pt 2):794-7. PubMed ID: 8395761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group.
    Baruch L; Anand I; Cohen IS; Ziesche S; Judd D; Cohn JN
    Circulation; 1999 May; 99(20):2658-64. PubMed ID: 10338459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.
    Widimský J; Kremer HJ; Jerie P; Uhlír O
    Eur J Clin Pharmacol; 1995; 49(1-2):95-102. PubMed ID: 8751029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Reid JL; MacFadyen RJ; Squire IB; Lees KR
    Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
    MacIntrye IM; Jhund PS; McMurray JJ
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):261-5. PubMed ID: 16187007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.
    Binkley PF; Haas GJ; Starling RC; Nunziata E; Hatton PA; Leier CV; Cody RJ
    J Am Coll Cardiol; 1993 Mar; 21(3):655-61. PubMed ID: 8436747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial.
    Houghton AR; Harrison M; Cowley AJ; Hampton JR
    Am Heart J; 2000 Nov; 140(5):e25. PubMed ID: 11054627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
    Szabó BM; van Veldhuisen DJ; van der Burgh PH; Kruik J; Girbes AR; Lie KI
    J Card Fail; 1996 Sep; 2(3):185-92. PubMed ID: 8891856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enalapril in the treatment of congestive heart failure.
    Giles T
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S6-10. PubMed ID: 1691416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.
    Rouleau JL; Pfeffer MA; Stewart DJ; Isaac D; Sestier F; Kerut EK; Porter CB; Proulx G; Qian C; Block AJ
    Lancet; 2000 Aug; 356(9230):615-20. PubMed ID: 10968433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.